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Although dichlorodiphenyl trichloroethane (DDT) is
being banned worldwide, countries in sub-Saharan Africa
have sought exemptions for malaria control. Few studies
show illness in children from the use of DDT, and the pos-
sibility of risks to them from DDT use has been minimized.
However, plausible if inconclusive studies associate DDT
with more preterm births and shorter duration of lactation,
which raise the possibility that DDT does indeed have such
toxicity. Assuming that these associations are causal, we
estimated the increase in infant deaths that might result
from DDT spraying. The estimated increases are of the
same order of magnitude as the decreases from effective
malaria control. Unintended consequences of DDT use
need to be part of the discussion of modern vector control
policy.
A
fter the Stockholm convention in 2001, which called
for the gradual ban of the persistent pesticide
dichlorodiphenyl trichloroethane (DDT), more than a
dozen countries in sub-Saharan Africa requested exemp-
tions for DDT use to control malaria (1). Discussions on
the health consequences of DDT use have focused on
reducing infant illness and death from vector control. The
possibility of observable toxicity has been minimized
because only a few studies show that DDTmay affect child
health and development (2–5). In laboratory experiments,
effects of DDT include hepatic and central nervous system
toxicity, estrogenic and antiandrogenic effects, and possi-
ble carcinogenicity (6,7). Some epidemiologic evidence
suggests that DDT exposure increases preterm delivery
and small-for-gestational-age births (8) and shortens the
duration of lactation (9,10); these conditions could
increase the rate of infant deaths (11,12) and thus attenuate
any benefits on mortality rates from a reduction in malar-
ia. While the observed associations between DDTand such
outcomes might not be causal, the studies are not so flawed
that the observations can be dismissed out of hand. We
attempted to estimate the consequences for infant deaths if
maternal DDT exposure in fact increases preterm births
and decreases the duration of lactation with the strength of
association seen in North America. If the associations are
causal but the estimated effect on death rates is very small
compared to the plausible benefits from vector control,
then whether the associations are causal does not impact
public health decisions. If, on the other hand, the estimat-
ed increases in infant death rates are similar to or larger
than the expected benefits, whether the association is
causal matters a great deal, and further investigation is
warranted, especially in areas where DDT is reintroduced.
Although DDT can be found in the lipid of human tis-
sues worldwide, and consequently in the fat of breast milk
(13), levels of DDT and its metabolites in breast milk are
much higher in areas where this insecticide has been
applied for malaria control (14). Here, we use published
data on the relationship between DDT spraying and levels
in maternal serum and breast milk in Africa to estimate the
increased exposure from spraying. We assume that, to
obtain the benefit of reduced risk for malaria in the infant,
the mother’s home must be treated and she must be
exposed. We then estimate the effect of that exposure on the
frequency of preterm births and on duration of lactation. We
assume these relationships to be causal. Whether they are
causal, and, if they are, whether the strengths of association
seen in North America would occur in Africa is not known.
Using infant-mortality rates specific to preterm births, or
odds ratios for infant deaths by month-specific breast-feed-
ing status, we estimated deaths attributable to the changed
preterm birth rate and to the shortened duration of lactation
that we assume would be caused by spraying DDT. 
Materials and Methods
The Medline database was searched for literature on
DDT home spraying for malaria control and its effect on
DDT concentration in serum samples or breast milk; DDT
levels in blood or milk and pregnancy outcome or lactation
duration; and pregnancy outcome or duration of lactation
and infant deaths. Published data were reviewed and rean-
alyzed, if necessary, to estimate our hypothesized increase
of infant deaths from DDT home spraying, consequent to
small, early births and shorter lactation.
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Effect of Spraying on DDT in Serum and Breast Milk
Three studies on DDT levels in serum or breast milk
from Kwa-zulu after DDT application for malaria control
showed much higher DDT, DDE (dichlorodiphenyl
dichloroethene, the most stable and persistent form of
DDT), and DDD (dichlorodiphenyl dichloroethane) levels
in the DDT-exposed group (14–16). Dwellings in the
exposed area were treated with DDT for vector control
(14). In the DDT-treated area, DDE concentration in serum
samples was 103±85 µg/L; in the control area, the concen-
tration was 6±7 µg/L (16). The median DDE levels in
breast milk fat in the treated area (5.2–7.7 mg/kg) were all
much higher than those in the control area (0.38–0.59
mg/kg) (14).
DDE and Preterm Birth
A study based on the U.S. Collaborative Perinatal
Project, which included 361 preterm births (<37 complet-
ed weeks’ gestation) out of 2,380 births (a rate of 151 per
1,000 births), indicated that the adjusted odds ratios (ORs)
of preterm birth increased steadily with increasing concen-
tration of maternal serum DDE (ORs=1, 1.5, 1.6, 2.5, 3.1
for DDE concentrations <15, 15–29, 30–44, 45–59, >60
µg/L, respectively) (8). The increase in serum DDE levels
from spraying is greater than the range seen in the United
States; the adjusted OR for the most highly exposed U.S.
group is 3.1, but we used a more modest increase for this
analysis (see below).
Preterm Delivery and Infant Death
The preterm delivery rate in sub-Saharan Africa ranged
from 5% to 22% (17–20) in studies from the 1990s, when
DDT was not used or used only in small amounts. A
Malawi study (18) showed that children born preterm had
a crude relative risk (RR) of 2 for infant death; preterm
birth accounted for 17% of infant deaths. Malaria itself
might increase preterm birth, but this factor is counted in
the contribution of malaria to infant deaths (see below).
The observed RR of 2 in Malawi is lower than that seen in
the United States and Canada, where mild (birth at 34–36
gestational weeks) and moderate (birth at 32–33 gestation-
al weeks) preterm births were linked to a >2.9 fold
increase in infant deaths (12). If we assumed that DDT use
increased the overall preterm delivery rate from 15% (the
midrange of the African rates) before spraying to 25% after
spraying (RR 1.7, well below the 3.1 seen in U.S. data),
and the RR of preterm birth for infant death is 2.0, we esti-
mated a 9% (=((p2*RR+1-p2)-(p1*RR+1-p1))/(p1*RR+1-
p1), p1=15%, p2=25%, RR=2) increase in total infant
deaths.
DDE and Duration of Lactation
Two birth cohort studies on DDE level in breast milk
and duration of lactation both showed a negative relation-
ship between DDE level and breast-feeding duration,
whether in North Carolina (10) or Mexico (9). Figure 1
shows similar trends in the decrease of duration of lacta-
tion from both of these geographic sites. With a breast milk
p,p’-DDE level of 5.0–7.5 mg/kg (fat basis), the median
duration of breast-feeding is expected to be 3–4 months,
down 40% to 50%, as compared with 7–8 months if p,p’-
DDE level falls into the 0–2.5 mg/kg category. 
Pooled analysis of data from 17 African countries from
the World Fertility Surveys and Demographic and Health
Surveys (DHS) in late 1970s and 1980s, when DDT was
not used in most of Africa, showed that the mean duration
of breast-feeding was 18.1 months (first quartile 12.0
months, median 18.8 months, and third quartile 23.7
months) (21). Another DHS dataset indicated the median
breast-feeding duration in Africa from 1986 to 1990 was
19.3 months (22). Thus, if we assume the proportional
decrease in duration of lactation attributable to high DDE
concentration in milk fat in Africa is similar to that seen in
North America, where we observed 40% shorter duration
of lactation in women with approximately 6 mg/kg com-
pared to women with approximately 0 mg/kg, and the
result  of spraying is to increase median DDE in milk fat
from 0.4–0.6 mg/kg to 5–8 mg/kg (see above), the median
expected duration of breast-feeding in areas with routine
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Figure 1. Levels of dichlorodiphenyl
dichloroethene (DDE, the most sta-
ble and persistent form of DDT), in
breast milk and duration of lactation.DDT application for malaria control should be approxi-
mately 11–12 months. The assumption of a similar relative
decrease was the simplest. Alternatively, at one extreme,
we could assume an absolute decrease of 5 months, from
19 to 13, as we progressed from low to high exposure
(Figure 1); at the other extreme, since the median duration
of lactation in Mexico was longer than that in North
Carolina, but the DDE-level specific durations were the
same, we could assume a median duration of 3 to 4 months
at the high level of exposure in Africa as well. 
Shorter Lactation and Infant Deaths
Shorter duration of lactation increases the risk for infant
and childhood deaths in both industrialized and developing
countries (23–25). The World Health Organization (WHO)
conducted a Mantel-Haenszel pooled analysis to review
the effect of breast-feeding on infant and child death rates
(11). The analysis identified breast-feeding as a strong pro-
tective factor against infant death, especially that caused
by infectious illnesses such as diarrhea and acute lower
respiratory tract infection. Breast-feeding was most protec-
tive in younger infants; nevertheless, it was still protective
at 9 to 11 months after birth (Figure 2). If the median dura-
tion of lactation were shortened from 19 months to 11–12
months because of high concentrations of DDE, we would
expect the proportion of children weaned before 12 months
of life to increase from ~25% to 50%. In Africa, where
prolonged breast-feeding is the norm, the risk of not being
breast-fed continues into the second year of life, with ORs
ranging from 8 in Ghana to 2 in Senegal (11). (Death after
1 year of age is no longer considered an infant death, but
ORs should not change abruptly between 12 and 19
months of age). In the WHO analyses, the ORs for breast-
feeding longer >1 year all were from Africa, and the ORs
for breast-feeding <1 year were from Asia or South
America. To estimate the effect of decreasing from a medi-
an duration of 19 months in Africa to 11 months, we used
the most stable African estimate, from Senegal, which is
2.9 at 19 months, and compared it to the pooled estimate
from Asia and South America at 11 months, which is 1.4.
Thus, if we assume the overall RR of infant death from this
degree of DDT-induced shortened lactation to be approxi-
mately 2.0, shortened lactation would result in a 20%
(=((p2*RR+1-p2)-(p1*RR+1-p1))/(p1*RR+1-p1), p1=25%,
p2=50%, RR=2) increase in infant mortality caused by
infectious diseases.
Increased Rate of Infant Death from 
Preterm Birth and Shorter Lactation
The reported infant mortality rate (IMR) of sub-
Saharan African countries was 108/1,000 in 2000,
110/1,000 in 1995, and 111/1,000 in 1990 (26). If DDT use
increases the IMR by 9% because of preterm delivery,
IMR will increase by approximately 9.7/1,000
(=108*9%/1,000). Infectious diseases account for more
than half of all infant deaths in Africa (27,28); thus, if DDT
use increases IMR attributable to infectious disease by
20% (through shorter breast-feeding), another 10.8/1,000
(=(108/2)*20%/1,000) will be added to the IMR in areas
with continuous DDT application for malaria control. The
results would be a total estimated excess of 20.5/1,000 in
IMR. On the other hand, maternal malaria caused 3% to
8% of all infant deaths in areas of Africa with stable malar-
ia transmission (29). Malaria itself caused 20% of deaths
in children <5 years of age (175/1,000 [30]) in Africa (31);
malaria-specific infant deaths were estimated to be
approximately 30% of such deaths (32). 
Discussion 
When we combine data from North America on preterm
delivery or duration of lactation and DDE with African
data on DDT spraying and the effect of preterm birth or
lactation duration on infant deaths, we estimate an increase
in infant deaths that is of the same order of magnitude as
that from eliminating infant malaria. Therefore, the side
effects of DDT spraying might reduce or abolish its bene-
fit from the control of malaria in infants, even if such
spraying prevents all infant deaths from malaria. However,
no studies from sub-Saharan Africa show that DDE short-
ens the duration of breast-feeding there specifically, and
studies showing the relationship in the United States and
Mexico both come from our group. Neither replications nor
replication failures have been reported from other groups
with longitudinal data. The relationship has a biologically
plausible mechanism, in that both isomers of DDE are
weak estrogens (33,34), and estrogen inhibits the stimula-
tory effect of prolactin on milk synthesis. (Awoman’s own
estrogen production is at its lowest postpubertal level at the
beginning of lactation.) Older birth control pills with high-
er estrogen levels were linked to a decrease in milk volume
or shortened duration of lactation (35).
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Figure 2. Protection of breast-feeding against infant death caused
by infectious disease (not breast-feeding versus breast-feeding).
CI, confidence intervals; OR, odds ratio. Source: World Health
Organization study team. In an attempt to replicate the finding on duration of lac-
tation and DDE, Bouwman enrolled lactating women in a
cross-sectional study comparing levels of DDE in milk in
areas using and not using DDT for malaria control. Even
though he did not follow children over time, this
researcher reasoned that, if DDE shortened lactation, chil-
dren of lactating mothers who had higher DDE levels
would be, on the average, younger. He found that the DDE
levels were much higher in the area where DDT was used
than in a control area, but the age of children and the num-
ber of women unable to give a milk sample did not differ.
This study is informative but cannot be interpreted as a
failure to replicate the duration finding, since women were
not followed over time, and, obviously, only women still
lactating were eligible (15). Roberts argues against the
causal nature of the association by observing that, in rou-
tinely collected data from Belize, rural women, who might
be exposed to DDT, breast-fed longer than urban women,
who probably were not exposed (36). However, these
women are otherwise probably not similar (e.g., in their
occupations or socioeconomic status). Nor is the classifi-
cation of exposure exact enough to detect even very large
effects of DDE. No studies in Africa show a relationship
between DDE and preterm birth. The findings from the
U.S. Collaborative Perinatal Project, while a confirmation
of previous, smaller studies, still need to be replicated in
Africa.
Another weakness of this analysis for current day sub-
Saharan Africa is that the contrasts in mortality rates
between breast-fed and bottle-fed children are derived
from older data, when the impact of HIV on infant deaths
was lower. In 1990, HIV caused 2% of deaths of children
<5 years of age, whereas by 1999 it caused almost 8%.
Five countries (Botswana, Namibia, Swaziland, Zambia,
and Zimbabwe) had HIV-attributable under-5 death rates
of approximately 30 per 1,000 (21% to 42% of total under-
5 mortality). An additional 16 countries had HIV-specific
under-5 mortality rates between 10 and 25 per 1,000 (8%
to 20% of total under-5 death rates). The remaining 18
countries had rates <10 per 1,000 (0.1% to 6.5% of total
under-5 deaths) (37). The effect of changing the duration
of breast-feeding on HIV mortality is hard to quantify
because, while any breast-feeding may increase transmis-
sion from infected mothers to infants, prolonged, exclusive
breast-feeding may decrease deaths and HIV transmission
(38). Such nonlinearities in dose-effect are difficult to
reduce to the relatively simple formulae required for the
kind of analysis presented here. Our conclusions are robust
if shorter duration of lactation does not eliminate transmis-
sion of HIV and consequent deaths; even then, HIV mor-
tality rates are likely only high enough in the five most
affected countries to cancel the protective effect of breast-
feeding entirely.
Our estimation provides a general framework of risk
evaluation in sub-Saharan Africa. However, the variation
in malaria transmission, illness, death, DDT spraying strat-
egy, incidence of preterm birth, and duration of lactation
should be kept in mind before the estimate is applied to a
specific country or area. Since we focused on infant
deaths, the benefits of DDT to child or adult malaria-spe-
cific deaths were not taken into account. Similarly, other
potential adverse effects to humans and the environment
that might occur from DDT spraying were not considered.
However, this analysis counters the assumption that the
risk of DDT use is unlikely to outweigh the benefit (39)
and requires that such an assumption be tested.
The prohibition of DDT use for malaria control was
probably not the sole cause of increasing malaria burden in
sub-Saharan Africa (40), and thus DDT will probably not
be the sole cure for the malaria epidemic there. Insecticide-
treated bed nets, widely used in African households to pre-
vent mosquito bites, are effective (41,42). Synthetic
pyrethroid insecticides, cheaper than DDT, are available
(43,44). Where DDT is used, all infant deaths, plus birth
weights and the duration of lactation, should be counted.
Some thought could also be given to a formal trial, since
the risk and benefit calculations apply to individual
dwellings, and an effective alternative, namely bed nets, is
available.
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